NIH-funded research R01 grant

Understanding how different drugs affect brain behavior and gene expression

Official title: Reprogramming KZFP function to understand drug-specific transcription and behavior

Funded at Virginia Commonwealth University · NIH-11078788 · Data updated 2026-11-12

This study is looking at how the brain reacts differently to addictions like cocaine and opioids, and it hopes to find new ways to help people struggling with these addictions by understanding the changes in brain cells caused by these drugs.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startMay 1, 2024
Project endFebruary 28, 2029
Funding year2025
Award (this year)$524,682
NIH project number5R01DA058089-02
Project IDNIH-11078788 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals struggling with stimulant addiction, particularly those with a history of cocaine use.

Less likely to help

Patients who are not addicted to stimulants or opioids may not benefit from this research.

What this research studies

This research investigates the molecular processes in the brain that differentiate addiction to stimulants like cocaine from addiction to opioids. By using synthetic transcription factors delivered to a specific brain region, the study aims to manipulate and understand how these factors influence gene expression related to drug addiction. The approach involves advanced techniques to analyze changes in brain cells in response to drug use, which could lead to new treatments for addiction. The findings could provide insights into the unique adaptations that occur in the brain due to different types of addictive substances.

Why it matters

Potential benefit: If successful, this research could lead to the development of targeted medications that are more effective in treating specific types of drug addiction.

How similar studies have gone: Previous research has shown promise in using synthetic transcription factors to manipulate gene expression, indicating potential for success in this novel approach.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Hamilton, Peter James — Virginia Commonwealth University
  • Study coordinator: Hamilton, Peter James

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.